“It was a wonderful meeting. There were fabulous speakers. The content was remarkable, and people attended from all over the world.” - John L. Marshall, MD, Georgetown University, USA on the previous year’s Congress.
Alpharetta, GA (PRWEB) January 28, 2013
ESMO and Imedex are pleased to announce the ESMO 15th World Congress on Gastrointestinal Cancer in Barcelona, Spain on 3-6 July 2013. This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by over nine leading professional societies and organizations.
With the focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms, the 2013 World Congress will educate and update the broad range of experts who participate in the treatment of gastrointestinal cancers, providing a clear overview for treatment.
Co-chaired by Mario DiCato, MD and Eric Van Cutsem, MD, PhD, the outstanding faculty is comprised of over 60 expert specialists who will lead the sessions and meet with participants in small targeted groups, making the scientific agenda the most comprehensive and most effective in addressing the educational needs of physicians. Thousands of participants attend each year, and their comments indicate that the update they receive is of immediate relevance to their practices.
Presentation of cutting-edge research is one of the highlights of the World Congress, offering opportunities for researchers worldwide to interact with colleagues and share their endeavors with the healthcare community. In 2012, over 350 abstracts were accepted for presentation and publication in a special supplement to the Annals of Oncology. Participation in the 2013 meeting is encouraged and interested parties should submit an abstract to be considered for presentation.
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe and around the world.
Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, education is the best medicine.®